Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash & Current Investments (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Cash & Current Investments data on record, last reported at $74.5 million in Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 11.08% year-over-year to $74.5 million; the TTM value through Dec 2025 reached $74.5 million, up 11.08%, while the annual FY2025 figure was $77.0 million, 32.78% down from the prior year.
  • Cash & Current Investments reached $74.5 million in Q4 2025 per PAHC's latest filing, down from $85.3 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $114.6 million in Q2 2024 and bottomed at $43.8 million in Q3 2021.
  • Average Cash & Current Investments over 5 years is $82.0 million, with a median of $83.3 million recorded in 2023.
  • Peak YoY movement for Cash & Current Investments: tumbled 52.37% in 2021, then soared 96.95% in 2022.
  • A 5-year view of Cash & Current Investments shows it stood at $63.4 million in 2021, then rose by 23.72% to $78.4 million in 2022, then rose by 17.94% to $92.5 million in 2023, then dropped by 27.48% to $67.1 million in 2024, then increased by 11.08% to $74.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $74.5 million in Q4 2025, $85.3 million in Q3 2025, and $77.0 million in Q2 2025.